Dr Tycel Phillips on Progress in B-cell Lymphoma TreatmentJune 5th 2023
In this interview, Tycel Phillips, MD, associate professor of medicine, Division of Lymphoma and Bone Marrow Transplantation, City of Hope, Duarte, California, discusses the advancements that are shaping the future of B-cell lymphoma treatment, as well as access barriers.
Contributor: Mental Health Conditions Rose Nationally in Share of Telehealth Claim LinesJune 5th 2023
In March 2023, national telehealth utilization rose 1.8%, up from 5.5% of medical claim lines in February, according to new data from FAIR Health’s Monthly Telehealth Regional Tracker.
Dr Bhagirathbhai Dholaria Discusses TRiMM-2 Trial FindingsJune 4th 2023
Bhagirathbhai R. Dholaria, MD, assistant professor of medicine in the Department of Hematology-Oncology at Vanderbilt University Medical Center, discussed findings from the phase 2 TRiMM-2 trial of talquetamab plus daratumumab in multiple myeloma.
Social Determinants of Health Impact Germline Testing Rates Among Patients With TNBCJune 4th 2023
Barb Kunz, MS, LCGC, senior genetic counselor at the US Oncology Network, shared insight on a study of social determinants of health in the context of germline genetic testing for triple-negative breast cancer (TNBC) in the community oncology setting.
Osimertinib Shows Significant OS Benefit in Patients With Resected, EGFRm NSCLCJune 4th 2023
Roy S. Herbst, MD, PhD, deputy director of Yale Cancer Center and lead investigator for ADAURA, said the results erase any doubts about the use of osimertinib in early non–small cell lung cancer (NSCLC) for patients with EGFR mutations.
Group Highlights Discrepancies Between Claims, Survey Cost Data Among Medicare PatientsJune 4th 2023
With Medicare-aged Americans accounting for over 15% of the population and significant health care costs, stakeholders have leveraged various approaches, including the Medicare Current Beneficiary Survey, for estimating costs.
Dr Samyukta Mullangi on the EOM: MIPS Disproportionately Penalizes Oncologists; ePROs Need RefiningJune 3rd 2023
"It's really important that oncologists are on level footing along with the rest of their medical peers," said Samyukta Mullangi, MD, MBA, incoming medical director at Thyme Care.
Dr Dennis Slamon on What Sets the NATALEE Trial Apart From Other Breast Cancer StudiesJune 3rd 2023
Dennis Slamon, MD, PhD, lead investigator on the NATALEE trial of ribociclib plus hormonal therapy in hormone receptor–positive, HER2-negative early-stage breast cancer, discussed the study's broad population and potential payer reactions.
Mandatory Switch Policies Drive Biosimilar Uptake, Reduce CostsJune 2nd 2023
Abstracts presented at EULAR 2023 highlighted the impact that a mandatory switching policy had on biosimilar uptake in British Columbia, Canada, and the lack of uptake when no such policy was in place in the United States.
Dr Surya Bhatt Discusses the Role of Dupilumab in Type 2 Inflammation, Exacerbations in COPDJune 2nd 2023
Surya Bhatt, MD, associate professor of medicine at University of Alabama at Birmingham, talks about a new trial in which dupilumab was used in patients with chronic obstructive pulmonary disease (COPD) with frequent exacerbations and type 2 inflammation.
US Government Spent Far More on Costly HIV PrEP Development Than Previously ThoughtJune 2nd 2023
According to new estimates, the US government spent between $143 million and $314 million in 2022 inflation-adjusted dollars funding the development of tenofovir disoproxil fumarate-emtricitabine. The previous estimate was around $50 million.
Dr Amal Agarwal: Value-based Contracts Can Help Align Incentives in DialysisJune 2nd 2023
Amal Agarwal, DO, MBA, chief clinical officer at Monogram Health, explains the importance of value-based agreements in dialysis care, and the issue of dialysis prevalence among low-income and marginalized communities.
What We’re Reading: Biden Eyes Cohen for CDC; Bias in PFTs; US Birthrate Stays FlatJune 2nd 2023
President Joe Biden has reportedly picked former North Carolina health chief Mandy Cohen, MD, MPH, as next head of the CDC; Black men were probably underdiagnosed with lung problems because of software bias; the US birthrate remains flat.
Unmet Needs in Myasthenia Gravis Are Numerous, Says Dr James HowardJune 2nd 2023
Unmet needs include both improved myasthenia gravis treatments as well as a way to monitor progression of the disease, said James F. Howard, Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill.
Medicare Patients With HSNCC Fare Better Than Younger CounterpartsJune 2nd 2023
Deemed the “Medicare” effect, patients aged 65 years who have Medicare coverage had an increased incidence of head and neck squamous cell carcinoma (HNSCC) but were less likely to receive a late-stage diagnosis and had lower mortality rates.